ARAV Gross Margin

The Gross Margin of Aravive Inc (ARAV) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ARAV Gross Margin - Historical Value

Date	Value
2022-12-31	7775.20%

ARAV Gross Margin - Peers Comparison

Ticker	Name	Value
950220.KQ	Neoimmunetech Inc	7775.20%
CDTX	Cidara Therapeutics Inc	97.62%
GILD	Gilead Sciences Inc	78.26%
950160.KQ	Kolon TissueGene Inc	11.72%
ABBV	Abbvie Inc	69.99%
AMGN	Amgen Inc	61.53%
ATNF	180 Life Sciences Corp	7775.20%
CRVS	Corvus Pharmaceuticals Inc	7775.20%
DYAI	Dyadic International Inc	65.82%
INMB	INmune Bio Inc	7775.20%
LPTX	Leap Therapeutics Inc	7775.20%
ONC.TO	Oncolytics Biotech Inc	7775.20%
SYBX	Synlogic Inc	7775.20%
950200.KQ	Psomagen Inc	23.13%
ANIX	Anixa Biosciences Inc	97.00%
MRZM	Marizyme Inc	70.87%
ORGS	Orgenesis Inc	-1080.19%
SLS	Sellas Life Sciences Group Inc	90.00%
TCON	TRACON Pharmaceuticals Inc	7775.20%
EVAX	Evaxion Biotech A/S	7775.20%
LGVN	Longeveron Inc	78.76%
PDSB	PDS Biotechnology Corp	7775.20%
ALRN	Aileron Therapeutics Inc	7775.20%
ATOS	Atossa Therapeutics Inc	100.00%
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
CLGN	Collplant Biotechnologies Ltd	-160.00%
MRNA	Moderna Inc	70.06%
RGLS	Regulus Therapeutics Inc	7775.20%
AYLA	Old Ayala Inc	-
CYCN	Cyclerion Therapeutics Inc	7775.20%
WLLW.TO	Willow Biosciences Inc	-809.99%
PSTI	Pluristem Therapeutics Inc	100.00%
PTN	Palatin Technologies Inc	97.83%
REGN	Regeneron Pharmaceuticals Inc	87.01%
SCPS	Scopus Biopharma Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%